Moderna Inc (MRNA)
159.50
-0.53 -0.33%
NASDAQ
Apr 15, 16:59
USD
Moderna Market Cap:
63.88B for April 15, 2021View 4,000+ financial data types
Browse...
View Full Chart
Market Cap Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Market Cap Data
View and export this data going back to 2018.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| April 15, 2021 | 63.88B |
| April 14, 2021 | 64.10B |
| April 13, 2021 | 59.96B |
| April 12, 2021 | 55.83B |
| April 9, 2021 | 56.44B |
| April 8, 2021 | 53.62B |
| April 7, 2021 | 52.66B |
| April 6, 2021 | 53.48B |
| April 5, 2021 | 52.03B |
| April 1, 2021 | 53.09B |
| March 31, 2021 | 52.45B |
| March 30, 2021 | 47.46B |
| March 29, 2021 | 49.43B |
| March 26, 2021 | 53.38B |
| March 25, 2021 | 53.40B |
| March 24, 2021 | 52.71B |
| March 23, 2021 | 54.68B |
| March 22, 2021 | 58.32B |
| March 19, 2021 | 57.57B |
| March 18, 2021 | 56.66B |
| March 17, 2021 | 59.10B |
| March 16, 2021 | 62.49B |
| March 15, 2021 | 57.54B |
| March 12, 2021 | 54.87B |
| March 11, 2021 | 56.26B |
| March 10, 2021 | 51.97B |
| March 9, 2021 | 52.42B |
| March 8, 2021 | 49.41B |
| March 5, 2021 | 52.90B |
| March 4, 2021 | 52.94B |
| March 3, 2021 | 52.51B |
| March 2, 2021 | 58.75B |
| March 1, 2021 | 62.99B |
| Feb. 26, 2021 | 61.89B |
| Feb. 25, 2021 | 59.32B |
| Feb. 24, 2021 | 57.88B |
| Feb. 23, 2021 | 60.03B |
| Feb. 22, 2021 | 63.71B |
| Feb. 19, 2021 | 69.86B |
| Feb. 18, 2021 | 67.79B |
| Feb. 17, 2021 | 70.66B |
| Feb. 16, 2021 | 71.37B |
| Feb. 12, 2021 | 73.27B |
| Feb. 11, 2021 | 73.15B |
| Feb. 10, 2021 | 71.52B |
| Feb. 9, 2021 | 71.59B |
| Feb. 8, 2021 | 74.17B |
| Feb. 5, 2021 | 70.28B |
| Feb. 4, 2021 | 69.11B |
| Feb. 3, 2021 | 66.14B |
| Feb. 2, 2021 | 63.24B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 52.97B |
| Gilead Sciences Inc | 82.81B |
| Johnson & Johnson | 421.81B |
Market Cap Range, Past 5 Years
| Minimum | 4.048B | Aug 05 2019 |
| Maximum | 74.17B | Feb 08 2021 |
| Average | 19.94B |
Market Cap Related Metrics
| PS Ratio | 75.70 |
| PEG Ratio | -3.268 |
| Price to Book Value | 24.94 |
| Price to Free Cash Flow | 31.04 |
| Price | 159.50 |
| Earnings Yield | -1.22% |
| PEGY Ratio | -3.268 |
News
Covid-19 Disease Triggers More Ultra-Rare Blood Clots Than Vaccines, Study Finds
Yahoo 04/15 15:47 ET
Yahoo 04/15 15:47 ET
Analyst Actions: Piper Sandler Adjusts Moderna's Price Target to $234 From $208, Maintains Overweight Rating
MT Newswires 04/15 06:45 ET
MT Newswires 04/15 06:45 ET
Advertisement
